Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 September - 2 October 2025
Herbal medicinal product: Calendulae flos, Calendula officinalis L., C: ongoing call for scientific data
PSUSA/00001760/202501
PSUSA/00001028/202411
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised
VICH GL62 on target animal safety of veterinary monoclonal antibody products (VMAPs) St4
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 23, Status: Authorised
Agenda - Management Board meeting: 2 October 2025
Agenda - Management Board meeting: 2 October 2025
Fees payable to the European Medicines Agency